|
PEN's Net Cash Flow Growth by Quarter and Year
Penumbra Inc's Net Cash Flow results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Net Cash Flow Growth Y/Y▼
|
Net Cash Flow Growth Y/Y▼
|
| PEN Net Cash Flow (in millions $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
| 4th Quarter |
December |
-
|
43.93
|
66.73
|
4.54
|
| 3rd Quarter |
September |
-
|
-7.86
|
-13.41
|
-3.39
|
| 2nd Quarter |
June |
-
|
65.22
|
19.48
|
-9.93
|
| 1st Quarter |
March |
51.65
|
55.63
|
24.83
|
8.78
|
| FY |
|
51.65
|
156.92
|
97.63
|
0.00
|
| PEN Net Cash Flow first quarter 2025 Y/Y Growth Comment |
Penumbra Inc reported decrease in Net Cash Flow in the first quarter 2025 by -7.15% to $ 51.65 millions, from the same quarter in 2024.
The decrease in the first quarter 2025 Penumbra Inc's Net Cash Flow compares unfavorably to the Company's average Net Cash Flow doubling of 179.56%.
Looking into first quarter 2025 results within Medical Equipment & Supplies industry 14 other companies have achieved higher Net Cash Flow growth. While Penumbra Inc' s Net Cash Flow decline of -7.15% ranks overall at the positon no. 387 in the first quarter 2025.
|
| PEN Net Cash Flow ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
December |
- |
-34.17 % |
1369.82 % |
- |
| 3rd Quarter |
September |
- |
- |
- |
- |
| 2nd Quarter |
June |
- |
234.8 % |
- |
- |
| 1st Quarter |
March |
-7.15 % |
124.04 % |
182.8 % |
- |
| FY |
|
- |
60.73 % |
- |
- |
PEN Net Cash Flow (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
December |
- |
- |
- |
- |
| 3rd Quarter |
September |
- |
- |
- |
- |
| 2nd Quarter |
June |
- |
17.24 % |
-21.55 % |
- |
| 1st Quarter |
March |
17.57 % |
-16.63 % |
446.92 % |
- |
| FY (Year on Year) |
|
- |
60.73 % |
- |
- |
| Net Cash Flow Y/Y Growth Statistics |
| High |
Average |
Low |
| 1371.42 % |
179.56 % |
-100 % |
| (Mar 31 2024) |
|
(Jun 30 2021) |
|
|
| Net Cash Flow Y/Y Growth Statistics |
| High |
Average |
Low |
| 1371.42 % |
179.56 % |
-100 % |
| (Mar 31 2024) |
|
(Jun 30 2021) |
|
| Net Cash Flow by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Penumbra Inc's Q/Q Net Cash Flow Growth
| Net Cash Flow Q/Q Growth Statistics |
| High |
Average |
Low |
| 447.52 % |
84.23 % |
-21.55 % |
| (Mar 31 2023) |
|
|
| PEN's I. Quarter Q/Q Net Cash Flow Comment |
Penumbra Inc achieved in the I. Quarter 2025 below company average Net Cash Flow jump of 17.57% quarter on quarter, to $ 51.65 millions.
I. Quarter 2025 Penumbra Inc's performance were paradoxical, even if lower than the regular increase of 84.23 %, yet it demonstrates absolute recovery compare to the -16.63% in the I. Quarter a year ago.
Within Medical Equipment & Supplies industry Penumbra Inc achieved highest sequential Net Cash Flow growth. While Penumbra Inc's Net Cash Flow growth quarter on quarter, overall rank is 26. |
|
|
|
| Net Cash Flow Q/Q Growth Statistics |
| High |
Average |
Low |
| 447.52 % |
84.23 % |
-21.55 % |
| (Mar 31 2023) |
|
|
| PEN's I. Quarter Q/Q Net Cash Flow Comment |
Penumbra Inc achieved in the I. Quarter 2025 below company average Net Cash Flow jump of 17.57% quarter on quarter, to $ 51.65 millions.
Although the I. Quarter 2025 PEN's results were below the average , that has been yet encouraging news, as the I. Quarter expension, eclipses the -16.63% growth in the I. Quarter 2024
Within Medical Equipment & Supplies industry Penumbra Inc achieved highest sequential Net Cash Flow growth. While Penumbra Inc's Net Cash Flow growth quarter on quarter, overall rank is 26. |
|
Penumbra Inc's 12 Months Net Cash Flow Growth Year on Year
Net Cash Flow TTM Growth |
12 Months Ending
(Mar 31 2025) |
12 Months Ending
(Dec 31 2024) |
12 Months Ending
(Sep 30 2024) |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
| Cumulative Net Cash Flow 12 Months Ending |
$ 152.94 |
$ 156.92 |
$ 179.72 |
$ 174.17 |
$ 128.43 |
| Y / Y Net Cash Flow Growth (TTM) |
19.09 % |
60.73 % |
407.19 % |
283.17 % |
700.36 % |
| Year on Year Net Cash Flow Growth Overall
Ranking |
# 14 |
# 53 |
# 43 |
# 50 |
# 306 |
| Seqeuential Net Cash Flow Change (TTM) |
-2.54 % |
-12.69 % |
3.19 % |
35.62 % |
31.55 % |
| Seq. Net Cash Flow Growth (TTM) Overall
Ranking |
# 53 |
# 130 |
# 169 |
# 112 |
# 189 |
| Cumulative Net Cash Flow growth Comment |
With the quarterly Net Cash Flow reported in the Mar 31 2025 period, Penumbra Inc's cumulative twelve months Net Cash Flow were $ 153 millions, company would post below average annual Net Cash Flow growth of 31.55% year on year, if the fiscal year would end at Mar 31 2025.
A slow-down in the Penumbra Inc's Net Cash Flow growth from the 43.93% growth in Dec 31 2024. Despite that, Penumbra Inc showed the highest Net Cash Flow growth, among it's peers in Medical Equipment & Supplies industry.
Penumbra Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While Total ranking has impoved so far to 14, from total ranking in previous quarter at 53. |
|
|
| Net Cash Flow TTM Y/Y Growth Statistics |
| High |
Average |
Low |
700.36 % |
126.27 % |
-191.22 % |
|
|
|
| Net Cash Flow TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 0 |
| Sector |
# 4 |
| S&P 500 |
# 53 |
|
| Cumulative Net Cash Flow growth
Comment |
With the quarterly Net Cash Flow reported in the Mar 31 2025 period, Penumbra Inc's cumulative twelve months Net Cash Flow were $ 153 millions, company would post below average annual Net Cash Flow growth of -191.22% year on year, if the fiscal year would end at Mar 31 2025.
A slow-down in the Penumbra Inc's Net Cash Flow growth from the 43.93% growth in Dec 31 2024. Despite that, Penumbra Inc showed the highest Net Cash Flow growth, among it's peers in Medical Equipment & Supplies industry.
Penumbra Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While Total ranking has impoved so far to 14, from total ranking in previous quarter at 53. |
| Net Cash Flow TTM Y/Y Growth Statistics |
| High |
Average |
Low |
700.36 % |
126.27 % |
-191.22 % |
|
|
|
| Net Cash Flow TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 0 |
| Sector |
# 4 |
| S&P 500 |
# 53 |
|
